Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Molecular testing of endometrial carcinoma in real-world clinical practice.

Klinicka onkologie : casopis Ceske a Slovenske onkologicke spolecnosti - 1 Jan 2023

Bednaříková M, Hausnerová J, Minář L, Taslerová R, Vinklerová P, Ehrlichová L, Trizuljak J, Blaháková I, Princ D, Matulová K, Ovesná P, Slabý O, Weinberger V

Abstract excerpt

BACKGROUND: Molecular classification has brought significant changes in the management of endometrial cancer (EC). In this article, we aim to analyze our first experience with an implementation of molecular testing into daily clinical practice. MATERIALS AND METHODS: In all newly diagnosed EC, the status of mismatch repair (MMR) and p53 proteins has been evaluated immunohistochemically as a part of the routine...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Aged
Share to DNA Mismatch Repair

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Endometrial Neoplasms

Share to Genetic Testing

Share to Molecular Diagnostic Techniques

Share to Mutation

Share to Tumor Suppressor Protein p53

Source

Identifiers

PMID: 37353351
DOI: 10.48095/ccko2023215

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-07.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Molecular testing of endometrial carcinoma in real-world clinical practice.PMID 37353351Read ↗

Initiation of molecular testing of endometrial carcinomas in a population‐based setting: practical considerations and pitfallsSemantic proximity Read ↗

Molecular testing for endometrial cancer: An SGO clinical practice statement.Semantic proximity Read ↗

Identification of molecular subtypes for endometrial carcinoma using a 46-gene next-generation sequencing panel: a retrospective study on a consecutive cohort.Semantic proximity Read ↗

Advantages of next-generation sequencing (NGS) in the molecular classifi cation of endometrial carcinomas - our experience with 270 cases.Semantic proximity Read ↗

Molecular Characterization and Clinical Implications of Endometrial Cancer.Semantic proximity Read ↗

Integrated clinicopathologic and molecular analysis of endometrial carcinoma: Prognostic impact of the new ESGO-ESTRO-ESP endometrial cancer risk classification and proposal of histopathologic algorithm for its implementation in clinical practiceSemantic proximity Read ↗

From Molecular Classification to Hereditary Cancer Syndrome Identification in Endometrial Cancer.Semantic proximity Read ↗

Implementation of the 2021 molecular ESGO/ESTRO/ESP risk groups in endometrial cancer.Semantic proximity Read ↗

Implementation of the 2021 molecular ESGO/ESTRO/ESP risk groups in endometrial cancerSemantic proximity Read ↗

Integration of clinical sequencing and immunohistochemistry for the molecular classification of endometrial carcinoma.Semantic proximity Read ↗

The relationship between histopathological data and molecular alterations with oncological outcomes in endometrioid-type endometrial cancers and a novel POLE mutation.Semantic proximity Read ↗

Clinical Application of Next-Generation Sequencing for Molecular Classification in the Management of Endometrial Cancer: An Observational Cohort StudySemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.